Literature DB >> 2526079

Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve.

G Stoll1, H W Meuller, B D Trapp, J W Griffin.   

Abstract

Apolipoprotein E (apoE), a lipid-binding glycoprotein involved in transport and metabolism of phospholipids and cholesterol, is synthesized and secreted at elevated rates following transection of mature rat peripheral and central nerves. In the peripheral nervous system (PNS) infiltrating macrophages express apoE during Wallerian degeneration. Following injury of the optic nerve (ON) apoE synthesis is significantly stimulated but the apoE-expressing cells have thus far not been identified. This study used 1 micron and thin cryosections to identify the cellular source of apoE in transected ON. Serial 1 micron frozen sections were stained by avidin-biotin-peroxidase complex immunocytochemistry by using a specific antiserum to apoE and by antibodies that identify different cell types: glial fibrillary acidic protein (GFAP) for astrocytes, 2',3'-cyclic nucleotide-3' phosphodiesterase (CNP) for oligodendrocytes, and ED1 for macrophages. In normal ON both astrocytes and oligodendrocytes were apoE-positive. One week after ON transection oligodendrocytes accounted for the majority of apoE-positive cells, while apoE immunoreactivity had disappeared from astroglial cell bodies and processes. In contrast to the PNS only a few ED1/apoE-positive macrophages were present in ON 7 days after transection. By using immunogold-labeled ultrathin cryosections apoE could be localized in the Golgi apparatus of oligodendrocytes, indicating synthesis by these cells. Our data suggest that oligodendrocyte-derived apoE protein may participate in the redistribution of myelin lipids after CNS injury.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526079     DOI: 10.1002/glia.440020306

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  9 in total

1.  The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.

Authors:  M Landén; A Thorsell; A Wallin; K Blennow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

2.  Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor.

Authors:  C R Gutman; W J Strittmatter; K H Weisgraber; W D Matthew
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

3.  Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injury.

Authors:  K Saito; M Seishima; M P Heyes; H Song; S Fujigaki; S Maeda; J H Vickers; A Noma
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

4.  Immunohistochemical study of apolipoprotein E in human cerebrovascular white matter lesions.

Authors:  H Tomimoto; I Akiguchi; T Suenaga; H Wakita; S Nakamura; J Kimura; H Budka
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

5.  Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System after Repetitive Mild Traumatic Brain Injury.

Authors:  Radouil Tzekov; Clint Dawson; Megan Orlando; Benoit Mouzon; Jon Reed; James Evans; Gogce Crynen; Michael Mullan; Fiona Crawford
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

6.  Nuclear Localization of Apolipoprotein E4: A New Trick for an Old Protein.

Authors:  Troy T Rohn; Zachary D Moore
Journal:  Int J Neurol Neurother       Date:  2017-07-31

7.  Resident Immunity in Tissue Repair and Maintenance: The Zebrafish Model Coming of Age.

Authors:  Raquel Rua Martins; Pam S Ellis; Ryan B MacDonald; Rebecca J Richardson; Catarina Martins Henriques
Journal:  Front Cell Dev Biol       Date:  2019-02-05

8.  Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Andreas Giannisis; Asma Al-Grety; Henrik Carlsson; Kalicharan Patra; Daniel Twohig; Sigrid Botne Sando; Camilla Lauridsen; Guro Berge; Gøril Rolfseng Grøntvedt; Geir Bråthen; Linda R White; Kim Kultima; Henrietta M Nielsen
Journal:  Alzheimers Res Ther       Date:  2022-08-24       Impact factor: 8.823

Review 9.  Deregulation of signalling in genetic conditions affecting the lysosomal metabolism of cholesterol and galactosyl-sphingolipids.

Authors:  S Gowrishankar; S M Cologna; M I Givogri; E R Bongarzone
Journal:  Neurobiol Dis       Date:  2020-10-17       Impact factor: 5.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.